The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of temozolomide (TMZ) in metastatic colorectal cancer (mCRC) patients molecularly selected by MGMT promoter hypermethylation.
 
Alessio Amatu
No Relationships to Disclose
 
Katia Bencardino
No Relationships to Disclose
 
Ludovic Barault
No Relationships to Disclose
 
Andrea Cassingena
No Relationships to Disclose
 
Erica Bonazzina
No Relationships to Disclose
 
Silvia Ghezzi
No Relationships to Disclose
 
Catia Moutinho
No Relationships to Disclose
 
Federica Tosi
No Relationships to Disclose
 
Riccardo Ricotta
Honoraria - GlaxoSmithKline; Janssen-Cilag; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Janssen-Cilag; Novartis; Pfizer; Sanofi
Research Funding - Bayer (Inst)
 
Elena Magni
No Relationships to Disclose
 
Rosalinda Gatto
Employment - CLIOSS
 
Giovanna Marrapese
No Relationships to Disclose
 
Manel Esteller
No Relationships to Disclose
 
Alberto Bardelli
Stock and Other Ownership Interests - Horizon Discovery
Consulting or Advisory Role - Horizon Discovery
 
Federica Di Nicolantonio
No Relationships to Disclose
 
Andrea Sartore-Bianchi
Consulting or Advisory Role - Amgen; Bayer; Merck Serono
 
Salvatore Siena
Consulting or Advisory Role - Amgen; Bayer; Celgene; Roche/Genentech; Sanofi